期刊文献+

肺癌淋巴结隐匿性微转移的基因诊断及其对预后的意义 被引量:8

Lymph Node Occult Micrometastasis in Patients with Non-Small Cell Lung Carcinoma: Genetic Diagnosis and Its Impact on Prognosis
暂未订购
导出
摘要 背景与目的:常规病理检查漏诊的纵隔淋巴结隐匿性微小转移可能与肺癌的预后有关。本研究旨在探索肺癌纵隔淋巴结隐匿性微转移的诊断,并评价其对预后意义。方法:应用逆转录聚合酶链反应法(RT-PCR),对58例非小细胞肺癌手术后病理检查阴性的242组纵隔淋巴结(pN_0)进行研究,检测淋巴结中MUC1基因mRNA表达,诊断纵隔淋巴结隐匿性微转移。对全部病人随访3年,应用Kaplan-Meier法计算生存率,log-rank检验比较有、无淋巴结隐匿性微转移患者的生存差别。结果:16例患者的23组纵隔淋巴结中检测到MUC1基因mRNA表达,诊断为纵隔淋巴结隐匿性微转移,占全部患者的27.6%。患者的TNM分期由Ⅰ_A~Ⅱ_B期上调为Ⅲ_A期。纵隔淋巴结隐匿性微转移组3年生存率为43.7%(7/16),无转移组的3年生存率为73.8%(31/42)。两组的生存差别具有显著性(P<0.05)。结论:纵隔淋巴结中MUC1基因mRNA的表达与pN_0患者预后不良有关。提示肺癌患者纵隔淋巴结MUC1基因mRNA阳性表达,可以作为判断可能存在淋巴结隐性微转移的参考指标。 BACKGROUND & OBJECTIVE: occult micrometastasis to mediastina! lymph node, which could not be detected by routinely histopathologic examination, might be correlated with the prognosis of patients with non-small cell lung carcinoma (NSCLC). The aim of this stud y was to diagnose occult micrometastasis of mediastinal lymph node in NSCLC patients and evaluate its prognostic significance. METHODS: Using reverse transcription-polymerase chain reaction (RT-PCR), 242 stations of mediastinal lymph nodes, which were free of tumor determined by histopathologic examination(pNO), from 58 patients were examined for MUC1 gene mRNA and to diagnose occult micrometastasis. All the patients were followed-up for three years. The survival rate was calculated by Kaplan-Meier method and the survival was compared with log-rank test between the patients with and without occult nodal micrometastasis. RESULTS: The MUC1 gene mRNA was identified in 23 stations of lymph nodes from 16 patients, and nodal occult micrometastasis was diagnosed in the 27.6% of the patients. TNM staging for these patients was up-regulated from stage ⅠA - ⅡB to stage Ⅲ A. The 3-year survival rate in the patients with nodal occult micrometastasis (43. 7% ) was lower than that in the patients without nodal occult micrometastasis (73. 8% ) ( P < 0.05). CONCLUSION: The expression of MUC1 gene mRNA in mediastinal lymph node is associated with poor prognosis of NSCLC patients with pNO disease, suggesting that it may be an indicator of poor prognosis.
出处 《癌症》 SCIE CAS CSCD 北大核心 2003年第11期1204-1208,共5页 Chinese Journal of Cancer
关键词 肺癌 淋巴结隐匿性微转移 基因诊断 预后 逆转录聚合酶链反应 Lung neoplasms Occult micrometastasis Mediastinal lymph node Diagnosis MUC1 gene Prognosis
  • 相关文献

参考文献1

二级参考文献9

  • 1Izbicki JR,Passlick B,Hosch SB,et al.Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis[].Journal of Thoracic and Cardiovascular Surgery.1996
  • 2Nicholson AG,Graham AN,Pezzella F,et al.Does the use of immunohistochemistry to identify micrometastasis provide useful information in the staging of node-negative non-small cell lung carcinomas[].Lung Cancer.1997
  • 3Gusteron B.Are micrometastases clinically relevant[].British Journal of Hospital Medicine.1991
  • 4Wu J,Ohta Y,Minato H,et al.Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2. 0 cm or less in diameter[].The Annals of Thoracic Surgery.2001
  • 5PasslickB,IzbickiJR,KubuschokB,etal.Detectionofdissemina tedlungcancercellsinlymphnodes :impactonstagingandprogno sis[].The Annals of Thoracic Surgery.1996
  • 6Ho SB,Niehans GA,Lyftogt C,et al.Heterogenity of mucin gene expression in normal and neoplastic tissues[].Cancer Research.1993
  • 7Salerno CT,Frizelle S,Niehans GA et al.Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptasepolymerase chain reaction[].Chest.1998
  • 8Naruke T,Suematu K,Ishikawa S.Lymph node mapping and curability at various levels of metastasis in resected lung cancer[].Journal of Thoracic and Cardiovascular Surgery.1978
  • 9Noguchi S,Alihara T,Motomura K,et al.Detection of breast cancer micrometastasis in axillary lymph node by means of reverse transcriptasepolymerase chain reaction: comparison between MUC1 mRNA and keratin 19 mRNA amplification[].American Journal of Pathology.1996

共引文献17

同被引文献36

  • 1李玉,王润智.肺癌的淋巴结转移规律与肺癌系统纵隔淋巴结廓清术[J].医师进修杂志(外科版),2004,27(10):6-7. 被引量:11
  • 2张驰宇,徐顺高,黄新祥.一种新颖简便的荧光实时RT-PCR相对定量方法的建立[J].生物化学与生物物理进展,2005,32(9):883-888. 被引量:131
  • 3汤红平,张雅洁,顾莹莹,张惠球.VEGF-C和VEGF-D在乳腺癌中的表达及其作用[J].肿瘤,2006,26(6):551-554. 被引量:18
  • 4赵小刚,董晓鹏,彭传亮.肺腺癌VEGF-C、VEGF-D的表达与MVD、MLVD及淋巴转移的关系[J].中华胸心血管外科杂志,2007,23(2):110-113. 被引量:4
  • 5张潍,周斌,李芳等.中晚期肺癌的术中放射治疗[J].中华肿瘤杂志,2000,22(11):438.
  • 6Riquet M,Hidden G,Debesse B.Direct lymphatic drainage of lung segments to the mediastinal nodes.An anatomic study on 260 adults[J].J Thorac Cardiovasc Surg,1989,97(4):623-32.
  • 7Ayabe H,Tsuji H,Nakamura A,et al.Evaluation of hilar and mediastinal lymph node metastases in resected cases of bronchogenic carcinoma[J].Kyobu Geka,1994,47(1):28-32.
  • 8Watanabe Y,Hayashi Y,Takabatake I,et al.Clinical significance of extended mediastinal lymph node dissection on the basis of clinicopathological analysis of nodal involvement in bronchogeni inoma[J].Kyobu Geka,1994,47(1):4-9.
  • 9Keller S M,Adak S,Wagner H,et al.Mediastinal lymph node dissection improves survival in patients with stages Ⅱand Ⅲ a non-small cell lung cancer.Eastern Cooperative Oncology Group[J].Ann Thorac Surg,2000,70(2):358-366.
  • 10Nakanishi R,Osaki T,Nakanishi K,et al.Treatment strategy for patients with surgically discovered N2 stage Ⅲ A non-small cell lung cancer[J].Ann Thorac Surg,1997,64(2):342-348.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部